Ultrasound scans of salivary glands in Sjögren's and related autoimmune diseases
Compares salivary gland ultrasound in people with Sjögren's disease and other autoimmune diseases.
Plain-language title generated from the registry record
Registry title: Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
Key facts
- Where
- Brest, FranceSee the site
Where in France
- Chu BrestBrest, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Brest
- Trial code
- NCT06680310
- Record updated
- 8 November 2024
- Original description
Prospective multicenter cross-sectional study evaluating ultrasound of the main salivary glands (2 parotid and 2 submandibular) in patients with Sjögren's disease compared with patients with other connective diseases (rheumatoid arthritis (RA), lupus, scleroderma) and control patients (patient with dry syndrome without the above-mentioned autoimmune disease).Read full original descriptionShow less
Prospective Multicenter Study of Ultrasound Evaluation of Salivary Glands in Patients with Sjögren's Disease Compared with Patients with Connective Tissue Diseases (lupus, Scleroderma, Rheumatoid Arthritis) and Healthy Subjects with Dry Syndromes
Prospective multicenter cross-sectional study evaluating ultrasound of the main salivary glands (2 parotid and 2 submandibular) in patients with Sjögren's disease compared with patients with other connective diseases (rheumatoid arthritis (RA), lupus, scleroderma) and control patients (patient with dry syndrome without the above-mentioned autoimmune disease).
Inclusion: Major patients; Patients fulfilling Sjogren criteria (2012 and 2016 American-European criteria) or Lupus according to ACR 2019 criteria or RA according to ACR/EULAR 2010 criteria or scleroderma according to ACR-EULAR 2013 classification criteria or control patient (patient with dry syndrome felt without pre-cited autoimmune disease).
Exclusion: Uncooperative patient who has refused to participate in the study; Patients unable to understand the protocol, under guardianship or curatorship; Patients not affiliated to the French Social Security system.